BioNTech/Pfizer: BNT162b2

Vaccine Type: RNA

Developers: BioNTech, Pfizer

This vaccine may also be referred to as Tozinameran, Comirnaty

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 3 Trials

Phase 2: 4 Trials

Phase 3: 1 Trial

  • NCT04368728
    Argentina, Brazil, Germany, South Africa, Turkey, United States of America

Approvals: 50 Approvals

  • Argentina
  • Austria
  • Bahrain
  • Belgium
  • Bulgaria
  • Canada
  • Chile
  • Colombia
  • Costa Rica
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Ecuador
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Jordan
  • Kuwait
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Mexico
  • Netherlands
  • Norway
  • Oman
  • Panama
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Saudi Arabia
  • Singapore
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • United States

Registered Trials